SBIR Topic 74, Phase I, RBC Storage System to Minimize Storage Lesions

SBIR 主题 74，第一阶段，RBC 存储系统，以最大限度地减少存储损害

• 批准号: 8756926
• 负责人: Tatsuro Yoshida
• 金额: $ 19.51万
• 依托单位: NEW HEALTH SCIENCES, INC.
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-05 至 2014-03-04
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8756926
• 关键词: Biochemical; Biomechanics; Blood; Blood Banks; Carbon Dioxide; Contracts; Devices; Equipment; Erythrocytes; Goals; Hemolysis; Lesion; Life; Morphology; Oxygen; Phase; Procedures; Property; Small Business Innovation Research Grant; Solutions; System; Testing; Toxic effect; Transfusion; cost; design; meetings; novel; particle; prototype

The goal of this project is to develop a novel, low cost blood storage system that will and deliver red blood cells (RBC) of higher quality thereby reducing the harmful consequences of transfusion therapy. RBC are depleted of O2 and CO2 and stored under depleted condition. The stored RBC have shown higher efficacy and lower toxicity. The product is designed to be easily integrated into existing blood bank operating practices with minimal alteration in procedures, equipment or cost. The objective of this contract is to design and test the feasibility of a prototype pre-storage O2/CO2 depletion device and anaerobic storage bag capable of meeting a the cost constraints of a commercial release product (cost and product shelf life). A prototype anaerobic red blood cell conversion kit will be fabricated and benchtested.

该项目的目标是开发一种新型、低成本的血液储存系统，该系统将提供更高质量的红细胞（RBC），从而减少输血治疗的有害后果。RBC耗尽O2和CO2，并在耗尽条件下储存。储存的红细胞显示出更高的功效和更低的毒性。该产品设计为易于集成到现有血库操作实践中，对程序、设备或成本的改动最小。该合同的目的是设计和测试原型预储存O2/CO2消耗装置和厌氧储存袋的可行性，能够满足商业释放产品的成本限制（成本和产品保质期）。将制造原型厌氧红细胞转换试剂盒并进行基准测试。